Update on depression and age-related macular degeneration

Current Opinion in Ophthalmology

Volumn 24, Issue 3, 2013, Pages 239-243

  Casten, Robin J ^a   Rovner, Barry W ^b  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Age Related Macular Degeneration; Depression; Late Onset Vision Loss

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB;

BEHAVIOR THERAPY; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; FUNCTIONAL STATUS; HUMAN; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK FACTOR; SCREENING; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

AGED; BLINDNESS; DEPRESSIVE DISORDER; HUMANS; MACULAR DEGENERATION; PREVALENCE; RISK FACTORS; VISION, LOW;

EID: 84876286589     PISSN: 10408738     EISSN: 15317021     Source Type: Journal    
DOI: 10.1097/ICU.0b013e32835f8e55     Document Type: Review

References (36)

1. Steffens D, Fisher G, Langa K, et al. Prevalence of depression among older Americans: the aging, demographics and memory study. Int Psychogeriatr 2009; 21:879-888.
2. Cole M. Evidence-based review of risk factors for geriatric depression and brief preventive interventions. Psychiatr Clin N Am 2005; 28:785-803.
3. Nyman S, Gosney M, Victor C. The psychosocial impact of sight loss: an update of the evidence. Age and Ageing 2009; 38:ii65.
4. Huang C, Dong B, Lu Z, et al. Chronic diseases and risk for depression in old age: a meta-analysis of published literature. Ageing Res Rev 2010; 9:131-141.
5. Evans J, Fletcher A, Wormald R. Depression and anxiety in visually impaired older people. Ophthalmology 2007; 114:283-288.
6. Jones G, Rovner B, Crews J, Danielson M. Effects of depressive symptoms on health behavior practices among older adults with vision loss. Rehabil Psychol 2009; 54:64-172.
7. Rovner B, Ganguli M. Depression and disability associated with impaired vision: the MoVies Project. J Am Geriatr Soc 1998; 46:617-619.
8. Congdon N, O'Colmain B, Klaver C, et al. Causes and prevalence of vision impairment among adults in the United States. Arch Ophthalmol 2004; 122:477-485.
9. Casten R, Rovner B, Tasman W. Age-related macular degeneration and depression: a review of recent research. Curr Opin Ophthalmol 2004; 15:181-183.
10. Wysong A, Lee P, Sloan F. Longitudinal incidence of adverse outcomes of age-related macular degeneration. Arch Ophthalmol 2009; 127:320-327.
11. Tournier M, Moride Y, Ducruet T, et al. Depression and mortality in the visuallyimpaired, community-dwelling, elderly population of Quebec. Acta Ophthalmologica 2008; 86:196-201.
12. The CATT Research Group. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. NEJM 2011; 364:1897-908.
13. Rosenfeld P, Brown D, Heier J. Ranibizumab for neovascular age-related macular degeneration. NEJM 2006; 355:1419-1431.
14. Brown D, Kaiser P, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. NEJM 2006; 355:1432-1444.
15. Chang T, Bressler N, Fine J, et al. Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 2007; 125:1460-1469.
16. Casten R, Rovner B, Leiby B, Tasman W. Depression despite anti-VEGF treatment of AMD. Arch Ophthalmol 2010; 128:506-507.
17. Goldstein J, Massof R, Deremeik J, et al. Baseline traits of low vision patients served by private outpatient clinical centers in the United States. Arch Ophthalmol 2012; 130:1028-1037. This study describes psychosocial and functional characteristics of people seeking low-vision services, many of whom have AMD.
18. Zhang X, Bullard K, Cotch M, et al. Depression and functional vision loss are associated in persons aged 20 years in the United States, NHANES 2005-2008. Arch Ophthalmol (in press).
19. Bookwala J, Lawson B. Poor vision, functioning, and depressive symptoms: a test of the activity restriction model. Gerontologist 2011; 51:798-808. This study demonstrates that social isolation and physical limitations are the pathways by which impaired vision leads to depression.
20. Mathew R, Delbaere K, Lord S, Beaumont P. Depressive symptoms and quality of life in people with age-related macular degeneration. Ophthalmol Physiol Optics 2011; 31:375-380. This study documents the high rate of depression in AMD and demonstrates the role of functional limitations in the development of depression.
21. Rees G, Tee H, Marella M, et al. Vision-specific distress and depressive symptoms in people with vision impairment. IOVS 2010; 51:2891-2896.
22. Popescu M, Boisjoly H, Schmaltz H, et al. Explaining the relationship between three eye diseases and depressive symptoms in older adults. Invest Ophthalmol Vis Sci 2012; 53:2308-2313. This study compared rates of depression in subjects with three eye diseases and found that AMD subjects had the highest rate, and that depression was related to mobility restrictions.
23. American Academy of Ophthalmology Retina/Vitreous Panel. Age-related macular degeneration. San Francisco (CA). American Academy of Ophthalmology (AAO). 2008. www.AAO.org/ppp. [Accessed 8 February 2013]
24. Brown G, Brown M. Let us wake the nation on the treatment for age-related macular degeneration. Curr Opin Ophthalmol 2010; 21:169-171.
25. Rovner B, Casten R, Tasman W. Effect of depression on vision function in age-related macular degeneration. Arch of Ophthalmol 2002; 120:1041-1044.
26. Rover B, Casten R. Stability of visual acuity measurement in depression. Am J Geriatr Psychiatry 2005; 13:255-258.
27. Augustin A, Sahel J, Bandello F, et al. Anxiety and depression prevalence rates in age-related macular degeneration. Invest Ophthalmol Vis Sci 2007; 48:1498-1503.
28. Rees R, Fenwick E, Keeffe J, et al. Managing depression in patients with vision impairment: a descriptive study of practitioners' beliefs and confidence. Australas J Ageing 2011; 30:130-135. This descriptive study highlights the limited understanding of depression among eye health professionals.
29. Rees G, Mellor D, Heenan H, et al. Depression training program for eye health and rehabilitation professionals. Optom Vis Sci 2010; 87:494-500.
30. Brody B, Gamst A, Williams R, et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology 2001; 108:1893-1900.
31. Brody B, Roch-Levecq A, Gamst A, et al. Self-management of age-related macular degeneration and quality of life: a randomized controlled trial. Arch Ophthalmol 2002; 120:1477-1483.
32. Rovner B, Casten R, Hegel M, et al. Preventing depression in age-related macular degeneration. Arch Gen Psychiatry 2007; 64:886-892.
33. Horowitz A, Reinhardt J, Boerner K. The effect of rehabilitation on depression among visually disabled older adults. Aging Ment Health 2005; 9:563-570.
34. Girdler S, Boldy D, Dhaliwal S, et al. Vision self-management for older adults: a randomised controlled trial. Br J Ophthalmol 2010; 94:223-228.
35. Margrain T, Nollett C, Shearn J, et al. The Depression in Visual Impairment Trial (DEPVIT): trial design and protocol. BMC Psychiatry 2012; 12:1-8.
36. Owsley C, McGwin G. Depression and the 25-Item National Eye Institute Visual Function Questionnaire in older adults. Ophthalmology 2004; 111:2259-2264.